Lakeland Industries Inc. - 10-K Summary (Fiscal Year Ended Jan 31, 2009)
Business Context and Reporting Period
Lakeland Industries Inc. (NASDAQ: LAKE) is a manufacturer of safety garments and accessories for the industrial protective clothing market. The company operates manufacturing facilities in the U.S., China, Mexico, India, and Brazil. This report covers the fiscal year ended January 31, 2009. The company is classified as a smaller reporting company.
Key Financial Metrics
| Metric | Fiscal 2009 | Fiscal 2008 |
|---|---|---|
| Net Sales | $102.3 million | $95.7 million |
| Gross Profit | $28.0 million (27.3% margin) | $22.4 million (23.4% margin) |
| Operating Profit | $6.3 million (6.1% margin) | $5.0 million (5.2% margin) |
| Net Income | $4.5 million ($0.84 EPS) | $3.3 million ($0.60 EPS) |
| Cash and Equivalents | $2.8 million | $3.4 million |
| Working Capital | $70.9 million | $65.3 million |
| Total Debt (Revolving Credit) | $24.4 million | $8.9 million |
| Inventory | $57.1 million | $48.1 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 6.8% to $102.3 million, driven primarily by the acquisition of Qualytextil, S.A. (Brazil) in May 2008, which contributed $8.4 million in sales. International sales grew significantly to $25.6 million (25% of total sales) compared to $13.0 million in 2008.
- Margin Expansion: Gross margin improved to 27.3% from 23.4%, attributed to the high-margin Brazil operations (51.4% margin) and cost reduction initiatives from shifting production to China and Mexico. This offset a 26.3% decline in North American Tyvek sales over the prior four years.
- Expense Increases: Operating expenses rose 24.9% to $21.7 million, largely due to $2.9 million in operating costs from the new Brazilian subsidiary, higher freight costs, and expanded sales staff.
- Debt and Liquidity: Borrowings under the revolving credit facility increased by $15.5 million to $24.4 million, primarily to fund the Qualytextil acquisition and increased inventory levels. Cash flow from operations was $1.6 million, offset by a $5.7 million increase in inventory.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management anticipates R&D expenses will increase to approximately $350,000 in FY2010 to pursue new international products and CE certifications. The company expects continued growth in international markets (China, India, Brazil) to offset domestic declines in disposable Tyvek sales.
- Internal Control Material Weakness: The company identified a material weakness in internal controls related to its China operations. A senior manager was terminated and charged with fraud involving the sale of fabric waste over eight years. The company recovered approximately $580,000 in proceeds. A China Internal Control Committee has been established to remediate these issues.
- Supplier Concentration: DuPont remains the largest supplier, providing 48.5% of raw materials by dollar value in FY2009. Tyvek fabric constituted 35% of the cost of goods sold. The company has no long-term supply contracts with DuPont.
- Government Funding Risk: Approximately 20-50% of high-end chemical suit sales depend on federal, state, and local government funding (e.g., Homeland Security grants). Reductions in these appropriations could materially impact sales.
- Unusual Items: Other income included a net pretax gain of $247,000 related to the recovery of funds from the China fraud and a reversal of a tax liability settlement with the IRS ($207,000 reduction in tax expense).
Investor Verification Checklist
- Internal Controls: Verify the effectiveness of the new China Internal Control Committee and the status of the fraud investigation remediation.
- Supplier Dependency: Assess the risk of supply chain disruption or price increases given the 48.5% reliance on DuPont without long-term contracts.
- Debt Covenants: Review compliance with the $30 million revolving credit facility covenants (interest coverage, debt coverage, minimum net worth) given the high utilization ($24.4 million outstanding).
- Inventory Levels: Analyze the $9 million increase in inventory to ensure it aligns with sales forecasts and does not indicate obsolescence risks.
- Government Grants: Monitor the status of Homeland Security and Bio-Terrorism grant funding cycles, which drive a significant portion of high-margin chemical suit sales.